Delstrigo pill image

Delstrigo

doravirine/lamivudine/tenofovir DF (DOR/3TC/TDF)

Recommended initial regimen in certain clinical situations
Single-Tablet Regimen

Standard Dose

One tablet once daily without regard to food. Tablet contains 100 mg of the NNRTI doravirine plus 300 mg lamivudine and 300 mg tenofovir DF (TDF). Approved only for adults at this time.

Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose. Dose cannot be adjusted for people with kidney problems; Delstrigo is not recommended in people with estimated creatinine clearance less than 50 mL/min. Should not be used in people with moderate or severe kidney impairment or severe liver impairment.

Manufacturer

Merck and Co.
(800) 622-4477
delstrigo.com

AWP

$2,520.00/month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments